Colorectal Cancer – Executive Market Summary 2011
Timely Data Resources, Inc, May 2012, Pages: 18
The Colorectal Cancer Executive Market Summary 2011 provides an overview of the disease and related conditions, with incidence, prevalence and mortality numbers and percentages for major countries worldwide, information on diagnosis, staging, and prognosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the cancer market, as well as sales of leading drugs and therapies are provided.
Executive Market Summaries were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Executive Market Summary provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.
The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
The Colorectal Cancer Executive Market Summary 2011 provides an overview of the disease and related conditions, with incidence, prevalence and mortality numbers and percentages for major countries worldwide, information on diagnosis, staging, and prognosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the cancer market, as well as sales of leading drugs and therapies are provided.
I. OVERVIEW
Overview of the condition
II. INCIDENCE, PREVALENCE AND MORTALITY
Incidence Table (Canada, US, Argentina, Brazil, Mexico, Finland, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Sweden, Turkey, UK, China, India, Japan, Philippines, Thailand, Egypt, Kenya, Nigeria, South Africa, Africa, Americas, Eastern Mediterranean, Europe, Southeast Asia, Western Pacific, Worldwide)
Prevalence Table (Canada, US, Mexico, Denmark, Finland, France, Germany, Italy, Spain, Sweden, UK, China, India, Japan, Nordic Countries, Worldwide)
Mortality Table (Canada, US, Argentina, Brazil, Colombia, Mexico, Finland, France, Germany, Greece, Italy, Netherlands, Poland, Russian Federation, Spain, Sweden, UK, China, India, Japan, Philippines, Thailand, Egypt, South Africa, Africa, Americas, Eastern Mediterranean, Europe, European Union, Southeast Asia, Western Pacific, Worldwide)
III. DETECTION, STAGING AND PROGNOSIS
Screening
Symptoms
Diagnosis
Staging
Prognosis
IV. TREATMENT
Surgery
Chemotherapy
Radiation therapy
Biological therapy
V. DOSING AND TREATMENT COSTS
Dosing and drug costs for typical treatment regimens
VI. MARKET SIZE
Overall market size
Sales information for key pharmaceuticals
VII. COMMENTS
VIII. REFERENCES/RESOURCES
Product Samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
